Clinical Trial Update: A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor [Phase 2]

View source ↗

Summary

Phase 2 study of LY-2880070 in combination with gemcitabine for Ewing sarcoma, Ewing-like sarcoma, and desmoplastic small round cell tumor has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoplastic Small Round Cell Tumor
• Ewing Sarcoma
• Ewing-like Sarcoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• LY-2880070

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Ewing Sarcoma, Ewing-Like Sarcoma | Phase 2 | Status: COMPLETED